SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

Canaccord Genuity Initiates Coverage On Inari Medical with Buy Rating, Announces Price Target of $60

Canaccord Genuity initiates coverage on Inari Medical (NASDAQ:NARI) with a Buy rating and announces Price Target of $60.

Benzinga · -
Canaccord Genuity initiates coverage on Inari Medical (NASDAQ: NARI) with a Buy rating and announces Price Target of $60.